The role of immune checkpoint inhibition in the treatment of ovarian cancer

Overview of attention for article published in Gynecologic Oncology Research and Practice, November 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)

Mentioned by

news: 11 news outlets
patent: 2 patents

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 122 Dimensions

Readers on

mendeley: 181 Mendeley

Summary News Patents Wikipedia Dimensions citations

So far, Dimensions has found 122 publications that cite this research output.

122

The most recent citing publications are shown below. View all 122 publications that cite this research output on Dimensions.

Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer

Article in International Journal of Biological Sciences (January 2024)

Siglec-7 glyco-immune binding mAbs or NK cell engager biologics induce potent antitumor immunity against ovarian cancers

Article in Science Advances (November 2023)

The cancer glycocode as a family of diagnostic biomarkers, exemplified by tumor-associated gangliosides

Article in Frontiers in Oncology (October 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.